CDC opioid-guideline criticism and public-comment deadline

An advocacy analysis challenges the evidence base, MME assumptions, and policy effects associated with CDC opioid guidance, arguing that guideline-driven practice can restrict chronic-pain care. Its claims remain independently unverified; the related public-comment portal reportedly closed or was due to close on 2026-09-19, and no policy revision is confirmed.